Physician profile
George Mamo
NPI 1588716641
$5,385.72
in general payments reported to CMS, 2019-2025
42 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,227 · 2020: $258 · 2021: $565 · 2022: $1,393 · 2023: $839 · 2024: $869 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,866 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,866.02 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $846.52 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Janssen Biotech, INC. | $406.57 | 2019-2023 | Erleada |
| Sumitomo Pharma America, INC. | $352.77 | 2023-2024 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $332.16 | 2021-2022 | |
| Medtronic, INC. | $263.77 | 2022-2024 | Interstim |
| Abbvie INC. | $261.11 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $220.96 | 2019-2024 | |
| Progenics Pharmaceuticals, INC. | $215.79 | 2022-2024 | Pylarify |
| Boston Scientific Corporation | $213.44 | 2019-2024 | Spaceoar Vue System - 10ml |
| Ferring Pharmaceuticals INC. | $198.43 | 2019-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $188.77 | 2019-2023 | Provenge |
| Endo Pharmaceuticals INC. | $172.03 | 2019-2024 | Aveed, Xiaflex |
| Teleflex LLC | $138.73 | 2022 | |
| Immunitybio, INC. | $135.17 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $134.18 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Mamo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.